CORVUS PHARMACEUTICALS INC's ticker is CRVS and the CUSIP is 221015100. A total of 54 filers reported holding CORVUS PHARMACEUTICALS INC in Q4 2017. The put-call ratio across all filers is - and the average weighting 0.3%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q2 2024 | $13,000 | – | 7,238 | +5832.8% | 0.00% | – |
Q4 2023 | $0 | – | 122 | -55.1% | 0.00% | – |
Q3 2022 | $0 | -100.0% | 272 | -90.9% | 0.00% | – |
Q2 2021 | $8,000 | +166.7% | 3,000 | +200.0% | 0.00% | – |
Q1 2021 | $3,000 | +200.0% | 1,000 | +371.7% | 0.00% | – |
Q3 2020 | $1,000 | 0.0% | 212 | +0.5% | 0.00% | – |
Q2 2020 | $1,000 | – | 211 | +0.5% | 0.00% | – |
Q1 2020 | $0 | -100.0% | 210 | -17.0% | 0.00% | – |
Q3 2018 | $2,000 | – | 253 | +1586.7% | 0.00% | – |
Q2 2018 | $0 | – | 15 | +400.0% | 0.00% | – |
Q1 2018 | $0 | -100.0% | 3 | -96.4% | 0.00% | – |
Q4 2017 | $1,000 | -90.9% | 84 | -88.3% | 0.00% | – |
Q3 2017 | $11,000 | – | 720 | +2566.7% | 0.00% | – |
Q2 2017 | $0 | -100.0% | 27 | -76.9% | 0.00% | – |
Q1 2017 | $2,000 | 0.0% | 117 | -25.9% | 0.00% | – |
Q4 2016 | $2,000 | – | 158 | – | 0.00% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
ADAMS STREET PARTNERS LLC | 3,275,616 | $8,910,000 | 1.84% |
Novo Holdings A/S | 2,927,560 | $7,963,000 | 0.51% |
Puissance Capital Management LP | 38,010 | $103,000 | 0.44% |
CHI Advisors LLC | 364,132 | $990,000 | 0.39% |
BVF INC/IL | 1,742,112 | $4,739,000 | 0.29% |
Orbimed Advisors | 6,767,584 | $18,408,000 | 0.26% |
EcoR1 Capital, LLC | 737,612 | $2,006,000 | 0.15% |
Hikari Power Ltd | 60,959 | $166,000 | 0.02% |
BRIDGEWAY CAPITAL MANAGEMENT, LLC | 133,700 | $364,000 | 0.01% |
MILLENNIUM MANAGEMENT LLC | 1,192,742 | $3,244,000 | 0.00% |